Literature DB >> 16612439

"The first shot": the context of first injection of illicit drugs, ongoing injecting practices, and hepatitis C infection in Rio de Janeiro, Brazil.

Maria de Lourdes Aguiar Oliveira1, Mariana A Hacker, Sabrina Alberti Nóbrega de Oliveira, Paulo Roberto Telles, Kycia Maria Rodrigues do O, Clara Fumiko Tachibana Yoshida, Francisco I Bastos.   

Abstract

The context of first drug injection and its association with ongoing injecting practices and HCV (hepatitis C virus) infection were investigated. Injection drug users (IDUs) (N = 606) were recruited in "drug scenes" (public places, bars) in Rio de Janeiro, Brazil, interviewed, and tested for HCV. Sharing of needles/syringes was more prevalent at the first injection (51.3%) than at the baseline interview (36.8%). Those who shared syringes/needles at first injection were more likely to be currently engaged in direct/indirect sharing practices. Among young injectors (< 30 years), those reporting sharing of needles/ syringes at the first injection were about four times more likely to have been infected by HCV. Hepatitis C virus prevalence among active IDUs (n = 272) was 11%. Prison history and longer duration of drug injection were identified as independent predictors of HCV infection. To effectively curb HCV transmission among IDUs and minimize harms associated with risk behaviors, preventive strategies should target individuals initiating drug injection beginning with their very first injection and discourage the transition from non-injecting use to the self-injection of illicit drugs.

Entities:  

Mesh:

Year:  2006        PMID: 16612439     DOI: 10.1590/s0102-311x2006000400024

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  10 in total

1.  Socio-demographic correlates of injection drug use among male drug users: a cross sectional study in Nepal.

Authors:  Sanjeev Raj Neupane; Shiva Raj Mishra; Samaj Adhikari; Amod Kumar Poudyal
Journal:  J Community Health       Date:  2014-12

2.  "Injection first": a unique group of injection drug users in Tijuana, Mexico.

Authors:  Meghan D Morris; Kimberly C Brouwer; Remedios M Lozada; Manuel Gallardo; Alicia Vera; Steffanie A Strathdee
Journal:  Am J Addict       Date:  2011-12-15

Review 3.  Transition to injecting drug use in Iran: A systematic review of qualitative and quantitative evidence.

Authors:  Afarin Rahimi-Movaghar; Masoumeh Amin-Esmaeili; Behrang Shadloo; Alireza Noroozi; Mohsen Malekinejad
Journal:  Int J Drug Policy       Date:  2015-05-12

4.  A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations.

Authors:  Nathalie Removille; Alain Origer; Sophie Couffignal; Michel Vaillant; Jean-Claude Schmit; Marie-Lise Lair
Journal:  BMC Public Health       Date:  2011-05-19       Impact factor: 3.295

5.  Epidemiological aspects of HCV infection in non-injecting drug users in the Brazilian state of Pará, eastern Amazon.

Authors:  Aldemir B Oliveira-Filho; Leila Sawada; Laine C Pinto; Daiane Locks; Santana L Bahia; Jairo A A Castro; Renata B Hermes; Igor Brasil-Costa; Carlos E M Amaral; José Alexandre R Lemos
Journal:  Virol J       Date:  2014-02-25       Impact factor: 4.099

6.  Injecting drug use in Manipur and Nagaland, Northeast India: injecting and sexual risk behaviours across age groups.

Authors:  Gregory Armstrong; Amenla Nuken; Gajendra K Medhi; Jagadish Mahanta; Chumben Humtsoe; Melody Lalmuanpuaii; Michelle Kermode
Journal:  Harm Reduct J       Date:  2014-10-13

7.  When and how do individuals transition from regular drug use to injection drug use in Uganda? Findings from a rapid assessment.

Authors:  Matayo Baluku; Twaibu Wamala
Journal:  Harm Reduct J       Date:  2019-12-23

8.  Prevalence and Correlates of Providing and Receiving Assistance With the Transition to Injection Drug Use.

Authors:  Rachel E Gicquelais; Dan Werb; Charles Marks; Carolyn Ziegler; Shruti H Mehta; Becky L Genberg; Ayden I Scheim
Journal:  Epidemiol Rev       Date:  2020-01-31       Impact factor: 4.280

9.  HCV genotypes, characterization of mutations conferring drug resistance to protease inhibitors, and risk factors among blood donors in São Paulo, Brazil.

Authors:  Anna S Nishiya; Cesar de Almeida-Neto; Suzete C Ferreira; Cecília S Alencar; Claudia Di-Lorenzo-Oliveira; José E Levi; Nanci A Salles; Alfredo Mendrone; Ester C Sabino
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

10.  Phylogenetic analysis of the emergence of main hepatitis C virus subtypes in São Paulo, Brazil.

Authors:  Anna Shoko Nishiya; César de Almeida-Neto; Camila Malta Romano; Cecília Salete Alencar; Suzete Cleusa Ferreira; Claudia Di-Lorenzo-Oliveira; José Eduardo Levi; Nanci Alves Salles; Alfredo Mendrone-Junior; Ester Cerdeira Sabino
Journal:  Braz J Infect Dis       Date:  2015-08-19       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.